Literature DB >> 26001739

DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.

Lovisa Farnebo1, Annika Stjernström2, Mats Fredrikson3, Anna Ansell4, Stina Garvin5, Lena K Thunell6.   

Abstract

Head and neck squamous cell carcinomas (HNSCC) are a heterogenous group of tumors with a high rate of early recurrences, second primary tumors, and mortality. Despite advances in diagnosis and treatment over the past decades, the overall 5-year survival rate remains around 50%. Since the head-and neck-region is continuously exposed to potentially DNA-damaging exogenous and endogenous factors, it is reasonable to expect that the DNA repair genes play a part in the development, progression, and outcome of HNSCC. The aim of this study was to investigate the SNPs XPC A499V, XPD K751Q, XRCC1 R399Q, and XRCC3 T241M as potential risk factors and indicators of survival among Caucasian patients. One-hundred-sixty-nine patients as well as 344 healthy controls were included and genotyped with PCR-RFLP. We showed that XPC A499V was associated with increased risk of HNSCC, especially laryngeal carcinoma. Among women, XPD K751Q was associated with increased risk of oral SCC. Furthermore, XPD homozygous mutant individuals had the shortest survival time, a survival time that increased however after full dose radiotherapy. Wild-type individuals of XRCC3 T241M demonstrated an earlier age of onset. HPV-positive never smokers had lower frequencies of p53 mutation. Among HNSCC patients, HPV-positivity was significantly associated with XRCC1 R399Q homozygous mutant genotype. Moreover, combinations of putative risk alleles seemed to act synergistically, increasing the risk of HNSCC. In conclusion, our results suggest that SNPs of the DNA repair genes XPC, XPD, XRCC1, and XRCC3 may affect risk and survival of HNSCC.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HPV; Head and neck squamous cell carcinoma; Overall survival; XPC; XPD; p53

Mesh:

Substances:

Year:  2015        PMID: 26001739     DOI: 10.1016/j.dnarep.2015.05.003

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  8 in total

1.  Role of Xeroderma Pigmentosum Group D in Cell Cycle and Apoptosis in Cutaneous Squamous Cell Carcinoma A431 Cells.

Authors:  Ou-Gen Liu; Xiao-Yan Xiong; Chun-Ming Li; Xian-Sheng Zhou; Si-Si Li
Journal:  Med Sci Monit       Date:  2018-01-24

2.  A Polymorphism Located Near PMAIP1/Noxa Gene Influences Susceptibility to Hodgkin Lymphoma Development in South India

Authors:  Dimpal N Thakkar; Sunitha Kodidela; Selvarajan Sandhiya; Biswajit Dubashi; Steven Aibor Dkhar
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

Review 3.  Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review.

Authors:  Agata Dylawerska; Wojciech Barczak; Anna Wegner; Wojciech Golusinski; Wiktoria Maria Suchorska
Journal:  Med Oncol       Date:  2017-11-15       Impact factor: 3.064

4.  Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy.

Authors:  Ruoxin Zhang; Ming Jia; Huijing Xue; Yuan Xu; Mengyun Wang; Meiling Zhu; Menghong Sun; Jianhua Chang; Qingyi Wei
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

5.  Association of hOGG1 Ser326Cys, ITGA2 C807T, TNF-A -308G>A and XPD Lys751Gln polymorphisms with the survival of Malaysian NPC patients.

Authors:  Eng-Zhuan Ban; Munn-Sann Lye; Pei Pei Chong; Yoke-Yeow Yap; Siew Ying Crystale Lim; Hejar Abdul Rahman
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

6.  Comprehensive assessment of the association between XPC rs2228000 and cancer susceptibility based on 26835 cancer cases and 37069 controls.

Authors:  Yingqi Dai; Zhonghua Song; Jinqing Zhang; Wei Gao
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

7.  ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy.

Authors:  Maja Guberina; Ali Sak; Christoph Pöttgen; Ingeborg Tinhofer-Keilholz; Volker Budach; Panagiotis Balermpas; Jens Von der Grün; Claus Michael Rödel; Eleni Gkika; Anca-Ligia Grosu; Amir Abdollahi; Jürgen Debus; Claus Belka; Steffi Pigorsch; Stephani E Combs; David Mönnich; Daniel Zips; Chiara De-Colle; Stefan Welz; Annett Linge; Fabian Lohaus; Gustavo Baretton; Thomas Gauler; Michael Baumann; Mechthild Krause; Martin Schuler; Agnes Bankfalvi; Benedikt Höing; Stephan Lang; Martin Stuschke
Journal:  Pharmacogenomics J       Date:  2020-06-16       Impact factor: 3.550

Review 8.  Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta-analysis on HPV, p16, and TP53.

Authors:  Frans J Mulder; Damiana D C G Pierssens; Laura W J Baijens; Bernd Kremer; Ernst-Jan M Speel
Journal:  Head Neck       Date:  2020-10-23       Impact factor: 3.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.